MedTrace Logo

Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors

NCT01004783 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2015-05-07

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This clinical trial studies biomarkers in tumor tissue samples from young patients with very low risk Wilms tumors.

Conditions

Interventions

GENETIC

DNA methylation analysis

GENETIC

gene expression analysis

GENETIC

loss of heterozygosity analysis

GENETIC

microarray analysis

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Elizabeth J. Perlman, MD · Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01004783 on ClinicalTrials.gov